Glioblastoma

Showing NaN - NaN of 75

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

The PALSUR-study: Palliative Care Versus Surgery in High-grade

Recruiting
  • Glioblastoma
  • +3 more
  • Palliative Care
  • +2 more
  • San Francisco, California
  • +7 more
Nov 18, 2023

The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma

Recruiting
  • Glioblastoma
  • +4 more
  • Tumor resection
  • Tumor biopsy
  • San Francisco, California
  • +7 more
Nov 18, 2023

Supramaximal Resection Versus Maximal Resection for High-Grade

Recruiting
  • Glioblastoma
  • +11 more
  • Supramaximal resection
  • Maximal safe resection
  • San Francisco, California
  • +7 more
Nov 1, 2023

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    Glioblastoma Trial in Boston (ITI-1001)

    Not yet recruiting
    • Glioblastoma
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 13, 2023

    Glioblastoma, Glioma Trial in Denmark, Netherlands, United States (Selinexor)

    Terminated
    • Glioblastoma
    • Glioma
    • Boston, Massachusetts
    • +5 more
    Jan 24, 2023

    Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,

    Recruiting
    • Glioblastoma
    • +3 more
    • Nivolumab-Placebo
    • +4 more
    • Los Angeles, California
    • +3 more
    Jan 16, 2023

    Glioblastoma, Recurrent Glioblastoma Trial in United States (ASP8374, cemiplimab)

    Active, not recruiting
    • Glioblastoma
    • Recurrent Glioblastoma
    • Boston, Massachusetts
    • +3 more
    Jan 13, 2023

    Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

    Active, not recruiting
    • Anaplastic Astrocytoma
    • +2 more
    • Radiation Therapy
    • +2 more
    • Birmingham, Alabama
    • +162 more
    Dec 30, 2022

    Glioblastoma Trial in United States (Abemaciclib, Surgery)

    Active, not recruiting
    • Glioblastoma
    • Los Angeles, California
    • +6 more
    Dec 28, 2022

    Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Boston (CARv3-TEAM-E T cells)

    Not yet recruiting
    • Glioblastoma
    • +3 more
    • CARv3-TEAM-E T cells
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Dec 13, 2022

    Astrocytoma, Glioblastoma Trial in Spain, United States (CC-90010)

    Active, not recruiting
    • Astrocytoma
    • Glioblastoma
    • Jacksonville, Florida
    • +8 more
    Dec 14, 2022

    Glioblastoma Trial in Boston, New York, Philadelphia (Pembrolizumab, Bevacizumab, Re-irradiation)

    Active, not recruiting
    • Glioblastoma
    • Boston, Massachusetts
    • +4 more
    Dec 7, 2022

    Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)

    Active, not recruiting
    • Glioblastoma
    • +3 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Nov 16, 2022

    Glioblastoma Trial in Australia, United States (drug, radiation, biological)

    Completed
    • Glioblastoma
    • Los Angeles, California
    • +7 more
    Oct 3, 2022

    Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

    Terminated
    • Glioma
    • +23 more
    • Tucson, Arizona
    • +11 more
    Sep 30, 2022

    Molecular Genetic, Host-derived and Clinical Determinants of

    Active, not recruiting
    • Glioblastoma
    • Blood drawl
    • Boston, Massachusetts
    • +26 more
    Sep 13, 2022

    Glioma, Glioblastoma Trial in United States (Focused ultrasound (FUS))

    Active, not recruiting
    • Glioma
    • Glioblastoma
    • Focused ultrasound (FUS)
    • Baltimore, Maryland
    • +3 more
    Sep 8, 2022

    Advanced Malignant Solid Tumor, Glioblastoma, Recurrent Cholangiocarcinoma Trial in United States (Olaparib)

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +6 more
    • Costa Mesa, California
    • +49 more
    Aug 24, 2022

    Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Worldwide (biological, drug, other)

    Recruiting
    • Glioblastoma
    • +5 more
    • Ipilimumab
    • +4 more
    • Birmingham, Alabama
    • +19 more
    Aug 16, 2022

    Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

    Recruiting
    • Mesothelioma
    • +14 more
    • Los Angeles, California
    • +13 more
    Aug 16, 2022